Antibiotic resistance patterns of group B streptococcal clinical isolates

Infectious Disease in Obstetrics and Gynecology

Volumn 12, Issue 1, 2004, Pages 1-8

  Simoes, Jose A ^a,b   Aroutcheva, Alla A ^a   Heimler, Ira ^a   Faro, Sebastian ^a,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMPINAS   (Brazil)

^c Woman's Hospital of Texas   (United States)

Author keywords

Antibiotics; Group B streptococcus; Intrapartum prophylaxis; Resistance

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFAMANDOLE; CEFAZOLIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; NITROFURANTOIN; OFLOXACIN; PENICILLIN G; VANCOMYCIN;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHEMOPROPHYLAXIS; IN VITRO STUDY; NONHUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLINS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 3142692868     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440410001722269     Document Type: Article

References (26)

1. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998;11:497-513
2. Harrison LH, Ali D, Dwyer DM, et al. Relapsing invasive group B streptococcal infection in adults. Ann Internal Med 1995;123:421-7
3. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999;7:210-3
4. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci isolates to clindamycin and erythromycin. Obstet Gynecol 1998;92:258-61
5. Meyn LA, Hillier SL. Ampicillin susceptibilities of vaginal and placental isolates of group B streptococcus and Escherichia coli obtained between 1992 and 1994. Antimicrob Agents Chemother 1997;41:1173-4
6. Lin L, Song J, Kimber N, et al. The role of bacterial vaginosis in infection after major gynecologic surgery. Infect Dis Obstet Gynecol 1999;7:169-74
7. Scharg SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20
8. Anonymous. Early-Onset Group B Streptococcal Disease - United States, 1998-1999. MMWR Morb Mortal Wkly Rep 2000;49:793-6
9. Tyrrell GJ, Senzilet LD, Spika JS, et al. Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study - 1996. J Infect Dis 2000;182:168-73
10. Schwartz B, Schuchat A, Oxtoby MJ, et al. Invasive group B streptococcal disease in adults. J Am Med Assoc 1991;266:1112-4
11. Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B Streptococcus in non-pregnant adults. N Engl J Med 1993;328:1807-11
12. Blumberg HM, Stephens DS, Modanksy M, et al. Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis 1996;173: 365-73
13. Wessels MR, Kasper DL. The changing spectrum of group B streptococcal disease (editorial). N Engl J Med 1993;328:1843-4
14. Anonymous. Prevention of perinatal group B streptococcal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1996;45:1-24
15. American College of Obstetricians and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. American College of Obstetricians and Gynecologists, 1996
16. Betriu C, Gomez M, Sanchez A, et al. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994;38:2183-6
17. Rouse DJ, Andrews WW, Lin FC, et al. Antibiotic susceptibility profile of group B Streptococcus acquired vertically. Obstet Gynecol 1998;92:931-4
18. Liu JW, Wu JJ, Ko WC, Chuang YC. Clinical characteristics and antimicrobial susceptibility of invasive group B streptococcal infection in non-pregnant adults in Taiwan. J Formos Med Assoc 1997;96:628-33
19. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother 1998;42:1517-9
20. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, sixth edn; approved standard. NCCLS document M10A6, vol. 17, no. 1, Wayne, PA: National Committee for Clinical Laboratory Standards, 1997
21. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing; Ninth Informational Supplement. NCCLS Document M100-S9, vol. 19, no. 1, Wayne, PA: National Committee for Clinical Laboratory Standards, 1999
22. Matushek MG, Bonten MJ, Hayden MK. Rapid preparation of bacterial DNA for pulsed-field gel electrophoresis. J Clin Microbiol 1996;34:2598-600
23. Prevention of Perinatal Group B Streptococcal Disease. Revised Guidelines from the CDC. MMWR Morb Mortal Wkly Rep 2002;51(RR11):1-22
24. Baker CJ, Edwards MS. Group B streptococcal infections. In Remington J, Klein LO, eds. Infectious diseases of the fetus and newborn infant. Philadelphia: W.B. Saunders, 2001;742-811
25. McDuffie RS, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant Enterobacteriaceae after antibiotic usage for premature rupture of membrane and group B streptococcus carriage. Obstet Gynecol 1993;82:487-9
26. Amstey MS, Gibbs RS. Is penicillin G a better choice than ampicillin for prophylaxis of neonatal group B streptococcal infections? Obstet Gynecol 1994;84:1058-9